Sitlinger, A. P., Sachdev, R., Ubel, P. A., Wong, C., LeBlanc, T. W., Zhang, T., … Zafar, Y. (2018). Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs? In Journal of Clinical Oncology (Vol. 36, pp. 6620–6620). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.6620

Sitlinger, Andrea Phillips, Rishi Sachdev, Peter A. Ubel, Charlene Wong, Thomas William LeBlanc, Tian Zhang, David Anderson, and Yousuf Zafar. “Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs?” In Journal of Clinical Oncology, 36:6620–6620. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.6620.

Sitlinger AP, Sachdev R, Ubel PA, Wong C, LeBlanc TW, Zhang T, et al. Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs? In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 6620–6620.

Sitlinger, Andrea Phillips, et al. “Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs?” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 6620–6620. Crossref, doi:10.1200/jco.2018.36.15_suppl.6620.

Sitlinger AP, Sachdev R, Ubel PA, Wong C, LeBlanc TW, Zhang T, Anderson D, Zafar Y. Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs? Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 6620–6620.